NEW YORK and YANTAI, China, July 1, 2011 (GLOBE NEWSWIRE) -- Bohai Pharmaceuticals Group, Inc. (OTCBB:BOPH) (OTCQB:BOPH), a China-based pharmaceutical company engaged in the production, manufacturing and distribution of modernized traditional Chinese medicine (TCM) in China, today announced that the audit committee of the company's board of directors has appointed Marcum Bernstein & Pinchuk LLP as the company's new independent registered public accounting firm.
